Khiron Life Sciences Corp. (KHRN) (TSX-V.KHRN) announced Thursday that it has
begun to ship medical cannabis to Peru, after receiving a licence from the country's drug regulatory authority.
Khiron, which has already signed up 3,000 medical cannabis patients in Colombia, is distributing its products through Farmacia Universal – a Peruvian pharmacy chain with 10 locations in the country's capital, Lima. The company is currently shipping medical CBD products with plans to distribute THC-infused offerings to Peru by the end of the year.
According to Prohibition Partners – a UK-based cannabis consultancy – while the South American cannabis market has developed slower than anticipated, sales in the region are expected to reach as much as USD$12 billion by 2028.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.